Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference, Clinical Chemistry and Laboratory Medicine (CCLM), March 2020, De Gruyter,
DOI: 10.1515/cclm-2019-1160.
You can read the full text:

Read

Contributors

The following have contributed to this page